Affluent Medical : Liquidity contract implementation with Kepler Cheuvreux.
- Affluent Medical : Liquidity contract implementation with Kepler Cheuvreux.
- Affluent Medical, a French medtech specialising in the international development and industrial scale-up of innovative medical prostheses, at a clinical stage, to treat urinary incontinence and cardiac mitral valve pathology, today announces that it has entered into a liquidity contract with Kepler Cheuvreux to manage Affluent Medical's shares listed on Euronext Paris.
- The following resources will be allocated to the liquidity account:
The execution of the liquidity contract may be suspended:
By Affluent Medical, in the event that Kepler Cheuvreux has not made reasonable efforts to fulfil its obligations;
By Kepler Cheuvreux, when the information brought to its attention makes it impossible for it to continue to fulfil its obligations;
By Kepler Cheuvreux, when the amounts due to Kepler Cheuvreux under the liquidity contract have not been paid;
Under the conditions set out in Article 5 of AMF Decision No.
- The liquidity contract may be terminated:
At any time by Affluent Medical with two (2) working days notice;
At any time by Kepler Cheuvreux subject to thirty (30) calendar days' notice;
Without notice and without formality if the shares are transferred to another stock market.